etoposide has been researched along with Paraganglioma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choh, S; Iwasa, Y; Katayama, K; Kimura, H; Koguchi, N; Murakami, S; Okada, A; Takahashi, T; Takenaka, H; Tomoda, K | 1 |
Kobos, R; LaQuaglia, MP; Modak, S; Pandit-Taskar, N; Sait, S | 1 |
Mori, R; Sano, T; Sinotou, K; Takigawa, H; Tatara, K; Taue, R; Uno, S | 1 |
3 other study(ies) available for etoposide and Paraganglioma
Article | Year |
---|---|
Primary Malignant Lymphoma Originating from the Chest Wall without Preceding Pleural Disease.
Topics: Aged, 80 and over; Antineoplastic Agents, Phytogenic; Dyspnea; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Paraganglioma; Radiography, Thoracic; Thoracic Wall; Tomography, X-Ray Computed | 2017 |
Acute myeloid leukemia therapy elicits durable complete response in chemoradio-resistant metastatic paraganglioma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cytarabine; Dacarbazine; Daunorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Iodobenzenes; Leukemia, Myeloid, Acute; Male; Paraganglioma; Radiation Tolerance; Temozolomide | 2017 |
A case of pelvic malignant paraganglioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Etoposide; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pelvic Neoplasms; Radionuclide Imaging; Vincristine | 2001 |